ML took the hot topic of dilution off the table and created a nest egg moving forward. The nest egg will help launch CF and NTM. It will also send a message to interested pharmas that Insmed has the dollars to bring product to market. ML has done this drill before and with great success. That is all I need to know.
one of the things the market likes is knowing they will be able to move in and out of a stock without moving the price to much low float means low liquidity funds don't like being trapped in a stock. the added stock will help us in the long run and the funds knowing there will be more said shares add. as needed for money to make sure we can conclude our goal